The pancreas in human type 1 diabetes: Providing new answers to age-old questions

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 16, Issue 4, 2009, Pages 279-285

  Atkinson, Mark A ^a   Gianani, Roberto ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoimmunity; Histology; Islets; Pancreas; Type 1 diabetes

Indexed keywords

INSULIN;

CELL COMPOSITION; CELL DEATH; CELL DIVISION; CELL REGENERATION; HISTORY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; PANCREAS; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; MODELS, BIOLOGICAL; PANCREAS;

EID: 67651107348     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32832e06ba     Document Type: Review

References (32)

1. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619-633.
2. Foulis AK, Liddle CN, Farquharson MA, et al. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29:267-274.
3. Hanafusa T, Miyazaki A, Miyagawa J, et al. Examination of islets in the pancreas biopsy specimens from newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia 1990; 33:105-111. (Pubitemid 20060988)
4. Conrad B, Weidmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371: 351-355. (Pubitemid 24300620)
5. Ohashi K, Nakajima Y, Hisanaga M, et al. A solid and papillary (solid-cystic) tumor of the pancreas occurring in a 36-year-old man: report of a case. Surg Today 1993; 23:551-555. (Pubitemid 23166592)
6. Gianani R, Putnam A, Still T, et al. Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 2006; 91:1855-1861.
7. Dotta F, Censini S, van Halteren AG, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007; 104:5115-5120. (Pubitemid 47186185)
8. Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988; 9:151-159. (Pubitemid 19105415)
9. Foulis AK, Stewart JA. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 1984; 26:456-461.
10. Wong FS, Siew LK, Wen L. CD8+ T-cells and their interaction with other cells in damage to islet beta-cells. Biochem Soc Trans 2008; 36:316-320. (Pubitemid 351839323)
11. Willcox A, Richardson SJ, Bone AJ, et al. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009; 155:173-181.
12. Hanafusa T, Imagawa A. Insulitis in human type 1 diabetes. Diabetes 2008; 57:2883-2888. One of the more interesting 'forms' of diabetes to be recognized is that of so-called 'fulminate' disease and thus this work, through its histologic examination of pancreata from individuals with disease, is of particular merit.
13. Butler AE, Galasso R, Meier JJ, et al. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 2007; 50:2323-2331. (Pubitemid 47512399)
14. Foulis AK. In type 1 diabetes, does a noncytopathic viral infection of insulin-secreting B-cells initiate the disease process leading to their autoimmune destruction? Diabet Med 1989; 6:666-674.
15. Foulis AK, Jackson R, Farquharson MA. The pancreas in idiopathic Addison's disease: a search for a prediabetic pancreas. Histopathology 1988; 12:481-490. (Pubitemid 18186294)
16. In't Veld P, Lievens D, De Grijse J, et al. Screening for insulitis in adult autoantibody: positive organ donors. Diabetes 2007; 56:2400-2404.
17. Oikarinen M, Tauriainen S, Honkanen T, et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetes Care 2008; 31:1741-1742. This work, as has others, also supports the notion that insulitis is rare in non-T1D subjects who possess only a single autoantibody but in addition, notes interesting findings (not discussed within this review) that infection of pancreatic islet cells with enterovirus was present in this individual.
18. Diamantopoulos S, Allende G, Ferreira JM, et al. Retrospective assessment of islet cell autoantibodies in pancreas organ donors. Diabetologia 2008; 51:703-713. This work is very important with respect to the notion of whether a pancreas from an autoantibody positive individual, presumably 'compromised' by immune events, would function in a less than ideal fashion once transplanted; a notion that was not supported by the data in this report.
19. Akirav E, Kushner JA, Herold KC. Beta-cell mass and type 1 diabetes: going, going, gone? J Mol Histol 2008; 39:543-551.
20. Haller MJ, Gottlieb PA, Schatz DA. Type 1 diabetes intervention trials 2007: where are we and where are we going? Curr Opin Endocrinol Diabetes Obes 2007; 14:283-287.
21. Klinke DJ. Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus. PLoS ONE 2008; 3:e1374. An interesting meta-analysis that draws to the forefront, the question of, 'what percentage of b cells are destroyed at the symptomatic onset of T1D?'.
22. Atkinson MA, Rhodes CJ. Pancreatic regeneration in type 1 diabetes: dreams on a deserted islet? Diabetologia 2005; 48:2200-2202.
23. Meier JJ, Bhushan A, Butler AE, et al. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 2005; 48:2221-2228.
24. Meier JJ, Lin JC, Butler AE, et al. Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 2006; 49:1838-1844.
25. Butler AE, Huang A, Rao PN, et al. Hematopoietic stem cells derived from adult donors are not a source of pancreatic beta-cells in adult nondiabetic humans. Diabetes 2007; 56:2400-2404. (Pubitemid 47025449)
26. Meier JJ, Butler AE, Saisho Y, et al. Diabetes. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetologia 2007; 56:1810-1816.
27. Campbell-Thompson M, Dixon LR, Wasserfall C, et al. Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia 2009; 52:262-270. With therapeutic trials using growth factors as a means to induce β cell replication in settings of T1D, evidence from humans that localized production of such factors (e.g., gastrin) is capable of inducing such activities is of interest.
28. Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008; 322:1490-1494. With controversies abounding in studies of pancreatic regeneration in mouse versus humans, this work provides an important evolutionary evaluation of questions relevant to the concept.
29. Meier JJ. Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 2008; 51:703-713. An excellent overview of the means by which b cell replication/regeneration may, or may not, be approached in diabetes.
30. von Herrath M, Sanda S, Herold K. Type 1 diabetes as a relapsing-remitting disease? Nat Clin Pract Endo Metab 2007; 3:758-768. This work is interesting in its bringing to the forefront the notion that rather than a 'linear loss' in b cells numbers prior to the symptomatic onset of T1D, period of exacerbation and remission from the disease may occur.
31. Goland R, Freeby M, Parsey R, et al. 11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls. J Nucl Med 2009; 50:382-398. An important follow-up, in humans, to a proof-of-principle study performed in rats suggesting that PET imaging of the pancreas (capable of reflecting β cell function) was feasible.
32. Saisho Y, Harris PE, Butler AE, et al. Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. Diabetologia 2008; 51:1796-1802.